myTomorrows
Earlier access to innovative drugs worldwide.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
* | €10.0m | Series A | |
| Total Funding | 000k | ||
| EUR | 2023 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
myTomorrows operates in the healthcare sector, focusing on bridging the gap between patients with serious diseases and BioPharma companies developing new treatments. The company serves patients, healthcare professionals, and BioPharma companies by providing a platform that facilitates patient recruitment for clinical trials, expanded access management, and Real World data collection. myTomorrows generates revenue through partnerships with BioPharma companies, offering them services that streamline the process of patient recruitment and data collection. The business model is centered on creating a connected hub that supports both patients in need of new treatment options and BioPharma companies looking to bring their innovations to market more efficiently. The market it operates in includes the global healthcare and pharmaceutical industries, with a particular focus on innovative treatments and clinical trials.
Keywords: patient access, BioPharma, clinical trials, expanded access, Real World data, healthcare platform, patient recruitment, treatment options, serious diseases, healthcare professionals.